When the emergency ends, private insurers will no longer be required to cover COVID-19 testing and treatment with no cost-sharing. Most will still cover the tests but may impose cost-sharing, ...
ITHACA, N.Y.--(BUSINESS WIRE)--Rheonix Inc., a manufacturer of a highly advanced microfluidic molecular testing platform, announced the opening of Rheonix Laboratories LLC, a CLIA-certified clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results